Highlights and Quick Summary
- Ending Cash for the quarter ending December 31, 2022 was $-6 Million (a -136.24% decrease compared to previous quarter)
- Year-over-year quarterly Ending Cash increased by 61.49%
- Annual Ending Cash for 2022 was $4.08 Million (a -79.4% decrease from previous year)
- Annual Ending Cash for 2021 was $19.8 Million (a 101.86% increase from previous year)
- Annual Ending Cash for 2020 was $9.8 Million (a -37.64% decrease from previous year)
- Twelve month Ending Cash ending December 31, 2022 was $2.28 Million (a -53.22% decrease compared to previous quarter)
- Twelve month trailing Ending Cash decreased by -86.1% year-over-year
Trailing Ending Cash for the last four month:
| 31 Dec '22 | 30 Sep '22 | 30 Jun '22 | 31 Mar '22 |
|---|---|---|---|
| $2.28 Million | $4.88 Million | $4.08 Million | $16.4 Million |
Visit stockrow.com/BNTC
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Ending Cash of Benitec Biopharma Limited
Most recent Ending Cashof BNTC including historical data for past 10 years.Interactive Chart of Ending Cash of Benitec Biopharma Limited
Benitec Biopharma Limited Ending Cash for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | $-6.0 | $16.55 | $-4.55 | $-3.71 | $4.08 |
| 2021 | $-3.4 | $15.74 | $7.8 | $-2.02 | $19.78 |
| 2020 | $6.56 | $7.45 | $-1.6 | $-2.05 | $9.8 |
| 2019 | – | – | $-3.18 | $16.63 | $15.72 |
| 2018 | – | – | – | – | $12.47 |
| 2017 | – | – | – | $11.61 | $13.1 |
| 2016 | – | $10.15 | $-1.08 | $-2.04 | $13.28 |
| 2015 | – | – | $16.39 | $18.24 | $18.24 |
| 2014 | – | – | $22.95 | $28.79 | $28.8 |
| 2013 | $1.63 | – | – | – | $1.63 |
Business Profile of Benitec Biopharma Limited
Sector: Healthcare
Industry: Biotechnology